MiMedx Shares Owned By Institutions vs. Return On Asset

MDXG Stock  USD 9.22  0.16  1.77%   
Based on the key profitability measurements obtained from MiMedx's financial statements, MiMedx Group is yielding more profit at this time then in previous quarter. It has a moderate odds of reporting better profitability numbers in December. Profitability indicators assess MiMedx's ability to earn profits and add value for shareholders. At this time, MiMedx's Days Of Sales Outstanding is most likely to decrease significantly in the upcoming years. At this time, MiMedx's Net Income is most likely to increase significantly in the upcoming years. The MiMedx's current Net Income From Continuing Ops is estimated to increase to about 4.6 M, while Total Other Income Expense Net is forecasted to increase to (6.2 M).
For MiMedx profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MiMedx to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MiMedx Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MiMedx's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MiMedx Group over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.1)
Earnings Share
0.57
Revenue Per Share
2.447
Quarterly Revenue Growth
0.029
Return On Assets
0.1838
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MiMedx Group Return On Asset vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining MiMedx's current stock value. Our valuation model uses many indicators to compare MiMedx value to that of its competitors to determine the firm's financial worth.
MiMedx Group is rated below average in shares owned by institutions category among its peers. It is regarded second in return on asset category among its peers . The ratio of Shares Owned By Institutions to Return On Asset for MiMedx Group is about  370.78 . The MiMedx's current Return On Assets is estimated to increase to 0.30. Comparative valuation analysis is a catch-all technique that is used if you cannot value MiMedx by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

MiMedx Return On Asset vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

MiMedx

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
68.15 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

MiMedx

Return On Asset

 = 

Net Income

Total Assets

 = 
0.18
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

MiMedx Return On Asset Comparison

MiMedx is currently under evaluation in return on asset category among its peers.

MiMedx Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in MiMedx, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MiMedx will eventually generate negative long term returns. The profitability progress is the general direction of MiMedx's change in net profit over the period of time. It can combine multiple indicators of MiMedx, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-215.1 M-204.4 M
Operating Income37.1 M39 M
Income Before Tax30.6 M32.2 M
Total Other Income Expense Net-6.5 M-6.2 M
Net Income67.4 M70.8 M
Income Tax Expense-36.8 M-35 M
Net Income From Continuing Ops4.3 M4.6 M
Net Loss-33.1 M-31.4 M
Non Operating Income Net Other-20.7 K-21.7 K
Net Interest Income-6.3 M-6.6 M
Change To Netincome19.3 M14.4 M
Net Income Per Share 0.58  0.61 
Income Quality 0.40  0.38 
Net Income Per E B T 2.20  1.46 

MiMedx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on MiMedx. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MiMedx position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MiMedx's important profitability drivers and their relationship over time.

Use MiMedx in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MiMedx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will appreciate offsetting losses from the drop in the long position's value.

MiMedx Pair Trading

MiMedx Group Pair Trading Analysis

The ability to find closely correlated positions to MiMedx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MiMedx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MiMedx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MiMedx Group to buy it.
The correlation of MiMedx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MiMedx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MiMedx Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MiMedx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your MiMedx position

In addition to having MiMedx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate
Real Estate Theme
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All  Next Launch
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Correlation Analysis.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
To fully project MiMedx's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MiMedx Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MiMedx's income statement, its balance sheet, and the statement of cash flows.
Potential MiMedx investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although MiMedx investors may work on each financial statement separately, they are all related. The changes in MiMedx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MiMedx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.